MCLAUGHLIN JOHN
SEC insider (Form 3/4/5 filer). CIK 0001203240. Director at Sonoma Pharmaceuticals, Inc. (SNOA). 3 reported Form 4/5 transactions since Sep 2024; latest on Jul 9, 2026. Located in BOULDER, CO.
Companies MCLAUGHLIN JOHN has filed insider reports for
- Sonoma Pharmaceuticals, Inc. (SNOA): Director
MCLAUGHLIN JOHN
CIK: 0001203240
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SNOA
Sonoma Pharmaceuticals, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jul 9, 2026SNOA
Sonoma Pharmaceuticals, Inc.
AwardDirectStock option (right to buy)
10K shares- - Jan 2, 2026SNOA
Sonoma Pharmaceuticals, Inc.
AwardDirectStock option (right to buy)
10K shares- - Jan 2, 2025SNOA
Sonoma Pharmaceuticals, Inc.
AwardDirectStock option (right to buy)
7.5K shares-
1-3 of 3 transactions